SARTORIUS STEDIM, DEAR TO THE CORE (SELL; -29% DOWNSIDE)
23/02/21 -" Sartorius Stedim Biotech (Sell, France) ranks as a top-notch asset, with industry-leading return metrics (FY20 ROE of 26% vs 14% for AV peers). Since we noted its phenomenal run almost two years ..."
Pages
4
Language
English
Published on
23/02/21
You may also be interested by these reports :